Want to sell your cosmetics in europe? These are the documents you need before it's too late.
European cosmetic compliance is built on evidence.
Without adequate documentation, the safety assessment cannot be completed and the product may not legally enter the European market.
As expert in cosmetics regulation Toxi Plan gives you the tips about the key documents needed 
Requirements for cosmetic products manufactured outside the European union
For cosmetic products manufactured outside the European Union, particularly where complete raw material documentation cannot be provided, alternative technical and regulatory evidence may be accepted to support compliance with European Regulation (EC) No 1223/2009.
To facilitate the regulatory assessment and Product Information File (PIF) preparation, the following minimum documentation requirements must be fulfilled.
Please note that all documents must be:
- Issued on company letterhead,
- Dated and signed,
- Stamped with the company official seal/stamp,
- Written in English (or accompanied by an English translation).
1. Raw Materials and Formula Compliance
A. Full qualitative and quantitative formula (Mandatory)
European authorities expect manufacturers to understand the composition of their products.
Where unavoidable impurities exist, manufacturers must demonstrate that they comply with European cosmetic legislation and do not create a safety risk for consumers. That’s why a complete and exact qualitative and quantitative formula (Q&Q) of the finished product must be provided.
Requirements:
- Full ingredient list with exact percentages,
- INCI nomenclature only,
- No concentration ranges accepted,
- No missing ingredients.
B. Raw material impurities and contaminants declaration (Mandatory)
The manufacturer must provide a signed declaration confirming that:
- Raw materials and the finished product do not contain impurities or contaminants of toxicological concern; or
- If impurities are present, they are technically unavoidable, non-intentionally added, and compliant with the requirements of European cosmetic legislation;
- Their presence does not present any safety concern for the consumer under normal and reasonably foreseeable conditions of use.
C. Animal Testing and Nanomaterial Declarations
Two declarations are systematically requested during regulatory assessments:
- Animal testing declaration
- Nanomaterial declaration
Manufacturers must confirm that neither the finished product nor its ingredients have been tested on animals in a manner prohibited by European legislation. They must also confirm whether nanomaterials are present in the formulation.
D. Allergen Documentation: a frequent bottleneck
Fragrances, botanical extracts, flavors, and essential oils often contain allergens that require assessment.
Ideally, manufacturers should provide allergen certificates for the raw materials used.
When these certificates are unavailable, alternative evidence may include:
- Finished product allergen analysis reports
- Signed declarations confirming the absence of regulated cosmetic allergens
This step is frequently overlooked and often becomes a major obstacle during the preparation of the Product Information File.
2. Finished Product Safety Evidence
A. Stability and compatibility study (Mandatory)
A stability and packaging compatibility assessment is required to support the claimed shelf life and packaging suitability. Accepted approaches:
- Option 1 – Real-time stability : 30 months at room temperature.
- Option 2 – Accelerated stability : Minimum of 3 months at 40°C.
No specific accreditation or guideline is required under European cosmetic regulation, provided the study is scientifically justified and adequately documented.
If no acceptable stability data can be provided, additional testing may be required by the client before product commercialization in the European Union.
B. Safety / skin compatibility evidence (Mandatory)
European compliance requires evidence supporting the safety of the finished product. Accepted documentation may include:
- Patch test report,
- Cosmetovigilance or post-market safety data,
- Equivalent documented safety evidence.
These data help demonstrate that the product can be safely used under normal and reasonably foreseeable conditions.
If no acceptable evidence can be provided, additional testing may be required by the client before commercialization in the European Union
C. Good Manufacturing Practices (GMP) declaration (Mandatory)
The manufacturer must provide a declaration confirming compliance with Good Manufacturing Practices (GMP) applicable to cosmetic products.
A GMP certificate, ISO 22716 certificate, or signed manufacturer declaration may be accepted.
3. The Most Common Mistake Made by Non-EU Manufacturers
Many companies begin discussions with distributors, importers, or European brands before verifying whether their documentation package is complete.
As a result, regulatory gaps are often discovered late in the project, causing delays, additional testing costs, and postponed market launches.
Preparing the required documentation early significantly reduces these risks and accelerates access to the European market.
At Toxi Plan, we support manufacturers worldwide in preparing the technical and regulatory documentation required for EU cosmetic compliance.
Our experts review existing documentation, identify missing elements, and help build a compliant Product Information File (PIF) to facilitate market entry.
Whether you manufacture cosmetics in Asia, North America, South America, Africa, or the Middle East, our team can help you navigate European requirements and avoid costly regulatory surprises.
Disclaimer:
The information provided in this article is for informational and educational purposes only. It does not constitute legal advice nor a personalized regulatory consultation. Despite the care taken in drafting this article and verifying its sources, regulations evolve regularly and may be subject to differing interpretations depending on the specific context of each company, product, or market.
Toxi Plan®, its directors, and its employees shall not be held liable for any use made of the information contained in this article without further analysis tailored to a specific situation. Any regulatory or strategic decision should be based on a specific assessment carried out by a qualified professional, with due regard to the applicable regulations, including any provisions or regulatory practices entering into force after the date of publication.